Professor Kim Sang-woo of Yonsei University was selected in the next generation of scientists as the..

Professor Kim Sang-woo of Yonsei University was selected in the next generation of scientists as the winner of this 12 months’s Amjen Hanlim Biotechnology Award, and Dr. Bu Sung-ho of the Korea Advanced Institute of Science and Technology (KAIST) and Dr. Oh Hyung-chul of Yonsei University have been selected in the postdoctoral analysis class.

The Korea Institute of Science and Technology introduced on the twenty fourth that it held the “5th Amgen Hanlim Biotechnology Award Winner” award ceremony at the Hallimwon Hall on the twenty first.

The Amgen Korea and the Korea Institute of Science and Technology collectively established the Amgen Korea Bioengineering Award in 2021 to encourage analysis motivation and contribute to the growth of the biotechnology subject by discovering and awarding younger home researchers who’ve achieved excellent analysis outcomes in the subject of life science and biotechnology.

The award selects a complete of three individuals in two classes: next-generation scientists for researchers beneath the age of 45 and postdoctoral researchers for rising (non-executive) researchers at home analysis institutes. The winner of the next generation of scientists will obtain 40 million received in prize cash and a plaque, whereas the winner of the post-doctoral analysis institute will obtain 10 million received in prize cash and a plaque.

Professor Kim Sang-woo, the winner of the Next Generation Scientist class, stands out in each fundamental and software features in the fields of bioinformatics and genomics. It was extremely praised for its contribution to the identification of genetic ailments and the realization of precision medication, such as figuring out the genetic trigger of spinal dysplasia for the first time by dielectric knowledge evaluation and publishing it in the worldwide journal Nature this 12 months.

Dr. Bu Sung-ho, winner of the postdoctoral analysis class, is conducting glorious analysis in RNA-based gene regulation and therapy analysis, together with designing synthetic round RNAs that may selectively degrade messenger RNA (mRNA) of particular genes. Dr. Oh Hyung-chul developed a expertise to precisely consider the perform of mutations in giant portions based mostly on a brand new genome correction expertise to determine the mutation perform of numerous ailments such as most cancers.

“This year’s winners are outstanding young scientists who have made creative research results in fields close to human health,” mentioned Jeong Jin-ho, head of the Korea Institute of Science and Technology. “We will continue to discover promising talents in the biotechnology field with Amgen Korea to support them to continue their excellent research.”